Inkon Life Tech net profit up 14.36% in Q1 2025

INKON Life Technology today announced its first-quarter results for 2025, showcasing a net profit attributable to shareholders of CNY 29.99 million, a 14.36% increase compared to the same period last year. Revenue reached CNY 409.04 million, representing a slight decrease of 1.73%. The net cash flow from operating activities was CNY 68.68 million, a decrease of 32.86% year-over-year. Basic and diluted earnings per share both stood at CNY 0.0404. Total assets amounted to CNY 3.55 billion, an increase of 0.27% compared to the end of the previous year. The company also disclosed its acquisition of a 51% stake in Changsha KeXin Tumor Hospital for CNY 357 million, aimed at strengthening its position in oncology services.